<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-185
Date of Submission: 2025-05-02

This report was submitted by a Other Healthcare Professional from Baker, Brady and Davis Medical Center concerning patient ANON-PX-6578. The subject is an adult male with a significant medical history including atrial fibrillation, chronic kidney disease, seasonal allergies, osteoarthritis. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin administered via the Subcutaneous route at a dosage of 206mg, initiated on 2025-03-26 for Bacterial infection and discontinued on 2025-04-26; Atorvastatin administered via the Subcutaneous route at a dosage of 346mg, initiated on 2025-03-26 for Hypercholesterolemia and discontinued on 2025-04-26.

On approximately 2025-04-15, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Vomiting, Pruritus, Dizziness, Nausea. The Anaphylaxis was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Recovering'. The Vomiting was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed ask and advised agent. The current patient status regarding this symptom is 'Recovering'. The Pruritus was classified as Mild in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Recovering'. The Dizziness was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Nausea was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 3 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Magazine ago boy election black wonder seven challenge. Somebody idea threat film where movie.</data>
report_id: ADR-2025-185
report_date: '2025-05-02'
patient_details:
  patient_id: ANON-PX-6578
  gender: Male
  relevant_history:
  - atrial fibrillation
  - chronic kidney disease
  - seasonal allergies
  - osteoarthritis
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 206mg
  route_of_administration: Subcutaneous
  start_date: '2025-03-26'
  indication_for_use: Bacterial infection
  end_date: '2025-04-26'
- drug_name: Atorvastatin
  dosage: 346mg
  route_of_administration: Subcutaneous
  start_date: '2025-03-26'
  indication_for_use: Hypercholesterolemia
  end_date: '2025-04-26'
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2025-04-15'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: true
- symptom_name: Vomiting
  onset_date: '2025-04-15'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed ask and advised agent.
- symptom_name: Pruritus
  onset_date: '2025-04-15'
  severity: Mild
  outcome: Recovering
  intervention_required: true
- symptom_name: Dizziness
  onset_date: '2025-04-15'
  severity: Moderate
  outcome: Fatal
  intervention_required: false
- symptom_name: Nausea
  onset_date: '2025-04-15'
  severity: Severe
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 3
reporting_facility: Baker, Brady and Davis Medical Center
reporter_type: Other Healthcare Professional
notes: Magazine ago boy election black wonder seven challenge. Somebody idea threat
  film where movie.
